Colgate-Palmolive Analyst Price Targets

Wall Street analyst price targets and consensus rating for Colgate-Palmolive (CL).

Price Target Range — 9 Quarters

Analyst Consensus — 17 Analysts

12Buy

5Hold

Consensus RatingBuy# Analysts17Avg. Consensus PT$98Upside to Avg. PT+16.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 21, 2026	Piper Sandler	Michael Lavery	PT Cut	Overweight	$98→$95
Sep 8, 2026	RBC Capital	Nik Modi	Maintained	Outperform	$104
Aug 3, 2026	UBS	Peter Grom	PT Raise	Buy	$106→$109
Aug 3, 2026	TD Cowen	Robert Moskow	PT Raise	Hold	$85→$90
Aug 3, 2026	JP Morgan	Andrea Teixeira	PT Cut	Overweight	$104→$103
Aug 3, 2026	RBC Capital	Nik Modi	PT Raise	Outperform	$102→$104
Aug 3, 2026	Evercore ISI Group	Robert Ottenstein	PT Raise	Outperform	$100→$101
Jul 21, 2026	Barclays	Lauren Lieberman	PT Raise	Equal-Weight	$80→$87
Jul 16, 2026	JP Morgan	Andrea Teixeira	PT Raise	Overweight	$96→$104
Jul 16, 2026	UBS	Peter Grom	PT Raise	Buy	$100→$106
Jul 14, 2026	Citigroup	Filippo Falorni	PT Raise	Buy	$105→$110
Jul 9, 2026	Piper Sandler	Michael Lavery	PT Raise	Overweight	$92→$96
Jul 8, 2026	Wells Fargo	Chris Carey	PT Raise	Equal-Weight	$92→$95
Jun 11, 2026	Bernstein	Cristian Rios	Initiate	Market Perform	$96
May 5, 2026	Barclays	Lauren Lieberman	PT Raise	Equal-Weight	$79→$80
May 4, 2026	JP Morgan	Andrea Teixeira	PT Raise	Overweight	$95→$96
May 4, 2026	UBS	Peter Grom	PT Raise	Buy	$98→$100
May 4, 2026	RBC Capital	Nik Modi	Maintained	Outperform	$102
Apr 23, 2026	Morgan Stanley	Dara Mohsenian	PT Cut	Overweight	$100→$95
Apr 21, 2026	Rothschild & Co	Edward Lewis	Upgrade	Neutral→Buy	$93→$100

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Piper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95

Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $98 to $95.

Benzinga Newsdesk

PRO
RBC Capital Reiterates Outperform on Colgate-Palmolive, Maintains $104 Price Target

RBC Capital analyst Nik Modi reiterates Colgate-Palmolive (NYSE:CL) with a Outperform and maintains $104 price target.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $109

UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $106 to $109.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Colgate-Palmolive, Raises Price Target to $90

TD Cowen analyst Robert Moskow maintains Colgate-Palmolive (NYSE:CL) with a Hold and raises the price target from $85 to $90.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $103

JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $104 to $103.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Colgate-Palmolive, Raises Price Target to $104

RBC Capital analyst Nik Modi maintains Colgate-Palmolive (NYSE:CL) with a Outperform and raises the price target from $102 to $104.

Benzinga Newsdesk

Colgate-Palmolive Co

Colgate-Palmolive Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Piper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95

PRO
RBC Capital Reiterates Outperform on Colgate-Palmolive, Maintains $104 Price Target

PRO
UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $109

PRO
TD Cowen Maintains Hold on Colgate-Palmolive, Raises Price Target to $90

PRO
JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $103

PRO
RBC Capital Maintains Outperform on Colgate-Palmolive, Raises Price Target to $104

People Also Watch

People Also Watch

Colgate-Palmolive Co

Colgate-Palmolive Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROPiper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95

PRORBC Capital Reiterates Outperform on Colgate-Palmolive, Maintains $104 Price Target

PROUBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $109

PROTD Cowen Maintains Hold on Colgate-Palmolive, Raises Price Target to $90

PROJP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $103

PRORBC Capital Maintains Outperform on Colgate-Palmolive, Raises Price Target to $104

People Also Watch

People Also Watch

PRO
Piper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95

PRO
RBC Capital Reiterates Outperform on Colgate-Palmolive, Maintains $104 Price Target

PRO
UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $109

PRO
TD Cowen Maintains Hold on Colgate-Palmolive, Raises Price Target to $90

PRO
JP Morgan Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $103

PRO
RBC Capital Maintains Outperform on Colgate-Palmolive, Raises Price Target to $104